相关实验视频
Updated: Jul 26, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
在接受体外膜氧化治疗的患者中,炎症进展
Yan'er Yao1, Huiyuan Kang1, Ye Cheng1
1Department of Cardiology, the Xiamen Cardiovascular Hospital of Xiamen University, Xiamen, Fujian, China.
体外膜氧化 (ECMO) 支持心脏和肺功能,但可以引发炎症和全身炎症反应综合征 (SIRS). 了解ECMO诱导的炎症对于改善患者的治疗结果至关重要.
科学领域:
- 关键护理医学 关键护理医学
- 支持心肺血管的支持.
- 免疫学 免疫学 免疫学
背景情况:
- 身体外膜氧化 (ECMO) 是严重的心脏和肺衰竭的已知生命支持技术.
- 尽管使用日益增加,但显著的发病率和死亡率仍然存在,其潜在机制尚不清楚.
- 外体电路内的炎症进展是ECMO治疗的公认并发症.
研究的目的:
- 在接受ECMO的患者中审查炎症的病态发展.
- 总结ECMO期间免疫激活和炎症之间的关系.
- 为管理ECMO相关炎症的临床治疗策略提供信息.
主要方法:
- 对ECMO和炎症研究的文献综述.
- 在ECMO电路中,血液与物质相互作用引发的免疫系统激活途径的分析.
- 综合证据,将炎症反应与ECMO患者的临床结果联系起来.
主要成果:
- 血液暴露于ECMO电路刺激免疫系统,促进炎症反应.
- 这种免疫激活可以导致全身炎症反应综合征 (SIRS) 和器官功能障碍.
- 该综述详细介绍了ECMO患者炎症的病理进展情况.
结论:
- 炎症是ECMO的关键并发症,是由免疫系统激活引起的.
- 了解这些炎症机制对于开发有针对性的干预措施至关重要.
- 对管理ECMO诱导的炎症的进一步研究可能会改善患者的生存率并减少并发症.
更多相关视频
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
相关概念视频
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Acute Respiratory Failure-III
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...